Patient basic information Patient: Mr. Mark (Mark Lewis) Nationality: Tunisia Diagnosis: Lung cancer Clinical hospital: H0ZN Treatment: Immunotherapy + Targeted Treatment Accommodation: 11 days Treatment cost: approximately 618246 yuan Treatment effect: partial relief The patient is from Tunisia and was diagnosed with lung cancer locally. Upon arrival, the International Medical Service Team arranged for the first time multidisciplinary MDT clinics for patients, developed individualized clinical pathways based on the patient's examination reports and physical condition, and provided translation, escort and on-site services throughout the treatment process.
During the treatment process, the International Medical Service Team employed a comprehensive set of immunotherapies + targeted therapies, with the medical team closely monitoring the patient's indicators and dynamic adjustment programs. After 11 days of systemic treatment and rehabilitation management, the patient's condition gradually improved, and the test indicators returned to normal areas, successfully reaching the hospital standard. Treatment results: Patient's final part of relief.
At the time of discharge, the medical team developed a detailed return follow-up and rehabilitation plan for the patient, and continued to track recovery through a remote follow-up system. 'Mr. Liu Mark has criticized the case as a typical case of cross-border suspected seriousness clinical disease.
Liu 4 relies on a multidisciplinary collaborative mechanism to develop an immunotherapy + targeted treatment program for lung cancer, reflecting the comprehensive strength of Chinese hospitals in the field of suspected diagnostics, and a summary of how international medical services are regulated.